You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
安科生物(300009.SZ):注射用人生長激素新增生產線獲批
格隆匯 03-28 19:43

格隆匯3月28日丨安科生物(300009.SZ)公佈,近日,公司收到國家藥監局下發的《藥品補充申請批准通知書》,公司北區注射用人生長激素新增生產線(地址:合肥市高新區海關路4號安科生物)正式批准生產。

該次注射用人生長激素新增生產線是公司2018年非公開發行的募集資金承諾項目“年產2,000萬支重組人生長激素生產線擴建提升項目”,該生產線獲批後,將有效解決現有產能瓶頸問題,顯著提升公司主營產品人生長激素產能供給能力,擴大公司產業化規模,為公司進一步提高市場份額和產品市場佔有率奠定了基礎,有效提升公司的核心競爭力和持續盈利能力。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account